Dr. David Furman, PhD, is a leading researcher at the Buck Institute for Research on Aging and Stanford University School of Medicine. His work focuses on building organ-specific aging clocks and “inflammaging”—the gradual rise of chronic, low-grade inflammation that drives cardiovascular disease, metabolic dysfunction, and neurodegeneration. By tracking novel and advanced biomarkers such as CXCL9 and other important inflammatory biomarkers of aging, Dr. Furman identifies early biological shifts that standard healthcare often misses. His research-driven approach moves medicine from reactive treatment to proactive prevention, helping individuals preserve cognitive clarity, physical resilience, and independence by addressing the root biological causes of aging.

‍

Current Practice or Institution Affiliation

Professor at Buck Institute for Research on Aging; Head of the Stanford University 1,000 Immunomes Project; Scientific Advisory Board at EverSpan Life.

Education

PhD in Immunology, University of Buenos Aires School of Medicine, Argentina; Postdoc in Machine Learning and Aging Biology, Stanford University School of Medicine

Areas of Expertise

Applied Artificial Intelligence and Machine Learning, Biological Aging Clocks, Immunology, Inflammaging.

In simple terms, what is your specialty?

Decoding inflammation and the biology of aging by studying how the immune system influences disease risk.

Why is this critical for healthspan (not just lifespan)?

Many age-related diseases are driven by chronic inflammation; regulating the immune system preserves energy, cognitive clarity, physical resilience, and independence.

What is one misconception about your field?

You can’t feel chronic age-related inflammation; chronic inflammation is silent and invisible, occurring for years before any symptoms appear.

What early warning markers do most people overlook? And what happens long-term if this area is ignored?

People overlook subtle shifts in immune signaling molecules. These are triggered by how we treat our bodies and exposures throughout life. If ignored, it leads to cardiovascular disease, metabolic dysfunction, neurodegenerative conditions, and accelerated biological aging.

What does traditional healthcare get wrong about prevention?

It is designed to identify disease only once it is clinically significant, often dismissing subtle elevations as “normal” and failing to track long-term trends.

Why does advanced biomarker testing and tracking matter?

A single test is just a snapshot; tracking trends reveals the direction of health and allows for personalized interventions before decline accelerates.

Was there a defining moment in your career?

Being drawn to science by the fundamental question of what actually drives human health and disease, I realized that inflammation is a primary driver.

Why did you join EverSpan Life?

To close the gap between when biological changes begin and when intervention happens, and to translate complex science into actionable health strategies.

What excites you most about ESL’s mission?

The systems-level understanding of aging and the ability to bring advanced research lab insights into everyday decision-making.